Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15852-15859
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15852
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15852
Restricted fluid (n = 89) | Standard fluid (n = 96) | P value | |
Age (yr) | 64.7 ± 16.8 | 65.4 ± 17.6 | 0.78 |
Male/Female | 50/39 | 56/40 | 0.77 |
Body mass index | 21.9 ± 4.2 | 22.3 ± 3.8 | 0.50 |
ASA grade | 0.98 | ||
I | 29 | 30 | |
II | 37 | 41 | |
III | 23 | 25 | |
Dukes stage | 0.61 | ||
A | 9 | 8 | |
B | 54 | 65 | |
C | 26 | 23 | |
Comorbidity | 0.78 | ||
Cardiovascular diseases | 46 | 43 | |
Pulmonary diseases | 11 | 14 | |
Other diseases | 16 | 15 | |
Smokers | 21 | 19 | 0.53 |
Site of surgery | 0.81 | ||
Colon | 59 | 62 | |
Rectum | 30 | 34 | |
Type of surgery | 0.38 | ||
Laparoscopic | 27 | 35 | |
Open | 62 | 61 | |
Stoma | 12 | 15 | 0.68 |
Blood loss (mL) | 120 ± 46 | 133 ± 62 | 0.11 |
Length of operation (min) | 146 ± 52 | 154 ± 48 | 0.28 |
- Citation: Jie HY, Ye JL, Zhou HH, Li YX. Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer. World J Gastroenterol 2014; 20(42): 15852-15859
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15852